Loading…

Too Much and Too Little: Antidepressant Treatment in Stroke Survivors during the First Year

Background: Post-stroke depression (PSD) is the most frequent mental illness after stroke, affecting about 30% of stroke survivors and hampering rehabilitation outcome. While current guidelines recommend monitored antidepressant treatment (ADT) in PSD, the limited precision between the use and need...

Full description

Saved in:
Bibliographic Details
Published in:Journal of integrative neuroscience 2022-06, Vol.21 (4), p.108-108
Main Authors: Werheid, Katja, Volz, Matthias, Ladwig, Simon, Hackett, Maree
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c429t-f683629961b1e478d3336ac79fecb0f7f88e1dd06c1b6085449b30758e67625b3
cites cdi_FETCH-LOGICAL-c429t-f683629961b1e478d3336ac79fecb0f7f88e1dd06c1b6085449b30758e67625b3
container_end_page 108
container_issue 4
container_start_page 108
container_title Journal of integrative neuroscience
container_volume 21
creator Werheid, Katja
Volz, Matthias
Ladwig, Simon
Hackett, Maree
description Background: Post-stroke depression (PSD) is the most frequent mental illness after stroke, affecting about 30% of stroke survivors and hampering rehabilitation outcome. While current guidelines recommend monitored antidepressant treatment (ADT) in PSD, the limited precision between the use and need of ADT in clinical practice remains underassessed and poorly understood. Methods: Depression according to DSM criteria and ADT was assessed in n = 294 stroke survivors from two German rehabilitation centers about one, six, and twelve months after stroke. At each measurement occasion, PSD and current use of ADT was assessed, leading to four subgroups: PSD (yes/no) and ADT (yes/no). Frequencies of ADT and PSD were examined and analyzed with regard to depression severity (minor/major). Intra-individual trajectories were used to assess the persistence in ADT over- and undertreatment from a longitudinal perspective. Results: After one, 6 and 12 months, 36.7%, 31.1% and 25.5% of stroke survivors fulfilled the criteria for depression. Across all measurement occasions, 53% of depressed stroke survivors did not receive ADT, while 12% of the non-depressed did. ADT between stroke survivors with major or minor depression differed at baseline but not thereafter. Between 15–40% of the depressed without ADT experienced persisting undertreatment and 25–50% the non-depressed with ADT had not fulfilled depression criteria at an earlier time point. Conclusions: Depression occurred in one in three stroke survivors. Among these, only one in two received ADT, irrespective of PSD severity after discharge. In contrast, one in eight stroke survivors without depressive disorder received ADT, about half of them in the absence of earlier PSD. In conclusion, we found evidence of both under- and overtreatment of PSD with ADT, which emphasizes the need for a more stringent implementation of current PSD guideline recommendations.
doi_str_mv 10.31083/j.jin2104108
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_220f00101cd448759ff5ae3d3ba3cfc9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_220f00101cd448759ff5ae3d3ba3cfc9</doaj_id><sourcerecordid>2693776205</sourcerecordid><originalsourceid>FETCH-LOGICAL-c429t-f683629961b1e478d3336ac79fecb0f7f88e1dd06c1b6085449b30758e67625b3</originalsourceid><addsrcrecordid>eNpFkc1rGzEQxUVJoY7bY-865rKOPnalVW4h1EnAJYe4kNCD0EqjRNv1ypW0hv732dqlOc38hsd7MA-hr5SsOCUtv-xXfRgZJfVMH9CCykZWdd0-naEFYVRVgjfsEzrPuSczc0UW6Oc2Rvx9sq_YjA7_hU0oZYArfD2W4GCfIGczFrxNYMoO5i2M-LGk-Avw45QO4RBTxm5KYXzB5RXwOqRc8DOY9Bl99GbI8OXfXKIf62_bm7tq83B7f3O9qWzNVKm8aLlgSgnaUahl6zjnwlipPNiOeOnbFqhzRFjaCdI2da06TmTTgpCCNR1fovuTr4um1_sUdib90dEEfTzE9KJNKsEOoBkjnhBKqHXzY2SjvG8McMc7w623ava6OHntU_w9QS56F7KFYTAjxClrJhSXcyxpZml1ktoUc07g_0dToo-F6F6_F8LfAAEIfe0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2693776205</pqid></control><display><type>article</type><title>Too Much and Too Little: Antidepressant Treatment in Stroke Survivors during the First Year</title><source>Alma/SFX Local Collection</source><creator>Werheid, Katja ; Volz, Matthias ; Ladwig, Simon ; Hackett, Maree</creator><creatorcontrib>Werheid, Katja ; Volz, Matthias ; Ladwig, Simon ; Hackett, Maree</creatorcontrib><description>Background: Post-stroke depression (PSD) is the most frequent mental illness after stroke, affecting about 30% of stroke survivors and hampering rehabilitation outcome. While current guidelines recommend monitored antidepressant treatment (ADT) in PSD, the limited precision between the use and need of ADT in clinical practice remains underassessed and poorly understood. Methods: Depression according to DSM criteria and ADT was assessed in n = 294 stroke survivors from two German rehabilitation centers about one, six, and twelve months after stroke. At each measurement occasion, PSD and current use of ADT was assessed, leading to four subgroups: PSD (yes/no) and ADT (yes/no). Frequencies of ADT and PSD were examined and analyzed with regard to depression severity (minor/major). Intra-individual trajectories were used to assess the persistence in ADT over- and undertreatment from a longitudinal perspective. Results: After one, 6 and 12 months, 36.7%, 31.1% and 25.5% of stroke survivors fulfilled the criteria for depression. Across all measurement occasions, 53% of depressed stroke survivors did not receive ADT, while 12% of the non-depressed did. ADT between stroke survivors with major or minor depression differed at baseline but not thereafter. Between 15–40% of the depressed without ADT experienced persisting undertreatment and 25–50% the non-depressed with ADT had not fulfilled depression criteria at an earlier time point. Conclusions: Depression occurred in one in three stroke survivors. Among these, only one in two received ADT, irrespective of PSD severity after discharge. In contrast, one in eight stroke survivors without depressive disorder received ADT, about half of them in the absence of earlier PSD. In conclusion, we found evidence of both under- and overtreatment of PSD with ADT, which emphasizes the need for a more stringent implementation of current PSD guideline recommendations.</description><identifier>ISSN: 0219-6352</identifier><identifier>EISSN: 1757-448X</identifier><identifier>DOI: 10.31083/j.jin2104108</identifier><language>eng</language><publisher>IMR Press</publisher><subject>antidepressants ; depression ; rehabilitation ; serotonin reuptake inhibitors ; stroke ; treatment</subject><ispartof>Journal of integrative neuroscience, 2022-06, Vol.21 (4), p.108-108</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c429t-f683629961b1e478d3336ac79fecb0f7f88e1dd06c1b6085449b30758e67625b3</citedby><cites>FETCH-LOGICAL-c429t-f683629961b1e478d3336ac79fecb0f7f88e1dd06c1b6085449b30758e67625b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Werheid, Katja</creatorcontrib><creatorcontrib>Volz, Matthias</creatorcontrib><creatorcontrib>Ladwig, Simon</creatorcontrib><creatorcontrib>Hackett, Maree</creatorcontrib><title>Too Much and Too Little: Antidepressant Treatment in Stroke Survivors during the First Year</title><title>Journal of integrative neuroscience</title><description>Background: Post-stroke depression (PSD) is the most frequent mental illness after stroke, affecting about 30% of stroke survivors and hampering rehabilitation outcome. While current guidelines recommend monitored antidepressant treatment (ADT) in PSD, the limited precision between the use and need of ADT in clinical practice remains underassessed and poorly understood. Methods: Depression according to DSM criteria and ADT was assessed in n = 294 stroke survivors from two German rehabilitation centers about one, six, and twelve months after stroke. At each measurement occasion, PSD and current use of ADT was assessed, leading to four subgroups: PSD (yes/no) and ADT (yes/no). Frequencies of ADT and PSD were examined and analyzed with regard to depression severity (minor/major). Intra-individual trajectories were used to assess the persistence in ADT over- and undertreatment from a longitudinal perspective. Results: After one, 6 and 12 months, 36.7%, 31.1% and 25.5% of stroke survivors fulfilled the criteria for depression. Across all measurement occasions, 53% of depressed stroke survivors did not receive ADT, while 12% of the non-depressed did. ADT between stroke survivors with major or minor depression differed at baseline but not thereafter. Between 15–40% of the depressed without ADT experienced persisting undertreatment and 25–50% the non-depressed with ADT had not fulfilled depression criteria at an earlier time point. Conclusions: Depression occurred in one in three stroke survivors. Among these, only one in two received ADT, irrespective of PSD severity after discharge. In contrast, one in eight stroke survivors without depressive disorder received ADT, about half of them in the absence of earlier PSD. In conclusion, we found evidence of both under- and overtreatment of PSD with ADT, which emphasizes the need for a more stringent implementation of current PSD guideline recommendations.</description><subject>antidepressants</subject><subject>depression</subject><subject>rehabilitation</subject><subject>serotonin reuptake inhibitors</subject><subject>stroke</subject><subject>treatment</subject><issn>0219-6352</issn><issn>1757-448X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpFkc1rGzEQxUVJoY7bY-865rKOPnalVW4h1EnAJYe4kNCD0EqjRNv1ypW0hv732dqlOc38hsd7MA-hr5SsOCUtv-xXfRgZJfVMH9CCykZWdd0-naEFYVRVgjfsEzrPuSczc0UW6Oc2Rvx9sq_YjA7_hU0oZYArfD2W4GCfIGczFrxNYMoO5i2M-LGk-Avw45QO4RBTxm5KYXzB5RXwOqRc8DOY9Bl99GbI8OXfXKIf62_bm7tq83B7f3O9qWzNVKm8aLlgSgnaUahl6zjnwlipPNiOeOnbFqhzRFjaCdI2da06TmTTgpCCNR1fovuTr4um1_sUdib90dEEfTzE9KJNKsEOoBkjnhBKqHXzY2SjvG8McMc7w623ava6OHntU_w9QS56F7KFYTAjxClrJhSXcyxpZml1ktoUc07g_0dToo-F6F6_F8LfAAEIfe0</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Werheid, Katja</creator><creator>Volz, Matthias</creator><creator>Ladwig, Simon</creator><creator>Hackett, Maree</creator><general>IMR Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20220601</creationdate><title>Too Much and Too Little: Antidepressant Treatment in Stroke Survivors during the First Year</title><author>Werheid, Katja ; Volz, Matthias ; Ladwig, Simon ; Hackett, Maree</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c429t-f683629961b1e478d3336ac79fecb0f7f88e1dd06c1b6085449b30758e67625b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>antidepressants</topic><topic>depression</topic><topic>rehabilitation</topic><topic>serotonin reuptake inhibitors</topic><topic>stroke</topic><topic>treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Werheid, Katja</creatorcontrib><creatorcontrib>Volz, Matthias</creatorcontrib><creatorcontrib>Ladwig, Simon</creatorcontrib><creatorcontrib>Hackett, Maree</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of integrative neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Werheid, Katja</au><au>Volz, Matthias</au><au>Ladwig, Simon</au><au>Hackett, Maree</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Too Much and Too Little: Antidepressant Treatment in Stroke Survivors during the First Year</atitle><jtitle>Journal of integrative neuroscience</jtitle><date>2022-06-01</date><risdate>2022</risdate><volume>21</volume><issue>4</issue><spage>108</spage><epage>108</epage><pages>108-108</pages><issn>0219-6352</issn><eissn>1757-448X</eissn><abstract>Background: Post-stroke depression (PSD) is the most frequent mental illness after stroke, affecting about 30% of stroke survivors and hampering rehabilitation outcome. While current guidelines recommend monitored antidepressant treatment (ADT) in PSD, the limited precision between the use and need of ADT in clinical practice remains underassessed and poorly understood. Methods: Depression according to DSM criteria and ADT was assessed in n = 294 stroke survivors from two German rehabilitation centers about one, six, and twelve months after stroke. At each measurement occasion, PSD and current use of ADT was assessed, leading to four subgroups: PSD (yes/no) and ADT (yes/no). Frequencies of ADT and PSD were examined and analyzed with regard to depression severity (minor/major). Intra-individual trajectories were used to assess the persistence in ADT over- and undertreatment from a longitudinal perspective. Results: After one, 6 and 12 months, 36.7%, 31.1% and 25.5% of stroke survivors fulfilled the criteria for depression. Across all measurement occasions, 53% of depressed stroke survivors did not receive ADT, while 12% of the non-depressed did. ADT between stroke survivors with major or minor depression differed at baseline but not thereafter. Between 15–40% of the depressed without ADT experienced persisting undertreatment and 25–50% the non-depressed with ADT had not fulfilled depression criteria at an earlier time point. Conclusions: Depression occurred in one in three stroke survivors. Among these, only one in two received ADT, irrespective of PSD severity after discharge. In contrast, one in eight stroke survivors without depressive disorder received ADT, about half of them in the absence of earlier PSD. In conclusion, we found evidence of both under- and overtreatment of PSD with ADT, which emphasizes the need for a more stringent implementation of current PSD guideline recommendations.</abstract><pub>IMR Press</pub><doi>10.31083/j.jin2104108</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0219-6352
ispartof Journal of integrative neuroscience, 2022-06, Vol.21 (4), p.108-108
issn 0219-6352
1757-448X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_220f00101cd448759ff5ae3d3ba3cfc9
source Alma/SFX Local Collection
subjects antidepressants
depression
rehabilitation
serotonin reuptake inhibitors
stroke
treatment
title Too Much and Too Little: Antidepressant Treatment in Stroke Survivors during the First Year
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T22%3A26%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Too%20Much%20and%20Too%20Little:%20Antidepressant%20Treatment%20in%20Stroke%20Survivors%20during%20the%20First%20Year&rft.jtitle=Journal%20of%20integrative%20neuroscience&rft.au=Werheid,%20Katja&rft.date=2022-06-01&rft.volume=21&rft.issue=4&rft.spage=108&rft.epage=108&rft.pages=108-108&rft.issn=0219-6352&rft.eissn=1757-448X&rft_id=info:doi/10.31083/j.jin2104108&rft_dat=%3Cproquest_doaj_%3E2693776205%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c429t-f683629961b1e478d3336ac79fecb0f7f88e1dd06c1b6085449b30758e67625b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2693776205&rft_id=info:pmid/&rfr_iscdi=true